OncoSec Medical (ONCS)

AI Score

Unlock

0.28

0.07 (33.21%)

At close: Jun 23, 2023, 8:00 PM

OncoSec Medical Income Statement

Financials in USD. Fiscal year is August - July.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jul 31, 2021	Apr 30, 2021	Jan 31, 2021	Oct 31, 2020	Jul 31, 2020	Apr 30, 2020	Jan 31, 2020	Oct 31, 2019	Jul 31, 2019	Apr 30, 2019	Jan 31, 2019	Oct 31, 2018	Jul 31, 2018	Apr 30, 2018	Jan 31, 2018	Oct 31, 2017	Jul 31, 2017	Apr 30, 2017	Jan 31, 2017	Oct 31, 2016	Jul 31, 2016	Apr 30, 2016	Jan 31, 2016	Oct 31, 2015
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-32.65M	-34.4M	-37.01M	-42.76M	-43.65M	-45.26M	-48.38M	-44.71M	-44.11M	-46.6M	-43.4M	-40.72M	-37.8M	-32.75M	-30.42M	-35.5M	-37.88M	-37.68M	-36.11M	-29.4M	-24.67M	-21.77M	-21.45M	-22.11M	-23.8M	-25.45M	-26.89M	-26.9M	-26.64M	-24.22M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-32.72M	-35.77M	-37.51M	-43.51M	-43.37M	-44.16M	-47.58M	-43.21M	-43.66M	-46.59M	-43.13M	-40.79M	-37.78M	-32.46M	-30.27M	-35.2M	-38.38M	-40.81M	-39.14M	-32.59M	-27.09M	-21.75M	-21.45M	-22.11M	-23.8M	-25.45M	-26.89M	-26.9M	-26.64M	-24.22M
Net Income	-30.14M	-33.19M	-34.06M	-37.64M	-40.84M	-41.63M	-45.17M	-42.34M	-42.9M	-45.83M	-42.37M	-40.9M	-37.78M	-32.46M	-30.28M	-35.21M	-40.02M	-42.44M	-40.74M	-34.2M	-27.07M	-21.72M	-21.45M	-22.11M	-23.8M	-25.45M	-26.89M	-26.9M	-26.64M	-24.22M
Selling & General & Admin	10.88M	10.46M	11.19M	14.46M	14.79M	14.31M	14.28M	10.89M	11.78M	17.13M	18.31M	18.4M	17.36M	13.63M	11.97M	14.94M	17.38M	18.94M	18.69M	15.53M	12.29M	9.51M	9.5M	9.88M	10.85M	11.27M	12.14M	11.91M	11.09M	9.93M
Research & Development	21.77M	23.94M	25.82M	28.3M	28.85M	30.94M	34.1M	33.82M	32.33M	29.47M	25.09M	22.32M	20.43M	19.13M	18.45M	20.56M	20.49M	18.74M	17.42M	13.88M	12.38M	12.27M	11.95M	12.23M	12.95M	14.18M	14.74M	14.99M	15.54M	14.29M
Other Expenses	56.91K	68.97K	30.87K	-401	-2.58K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	32.65M	34.4M	37.01M	42.76M	43.65M	45.26M	48.38M	44.71M	44.11M	46.6M	43.4M	40.72M	37.8M	32.75M	30.42M	35.5M	37.88M	37.68M	36.11M	29.4M	24.67M	21.77M	21.45M	22.11M	23.8M	25.45M	26.89M	26.9M	26.64M	24.22M
Interest Expense	52.13K	23.96K	20.93K	19.4K	18.43K	17.77K	15.86K	16.63K	14.9K	10.26K	5.11K	3.89K	4.88K	-228.93K	23.77K	-140.48K	-141.47K	5.01M	4.75M	4.92M	4.92M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	32.65M	34.4M	37.01M	42.76M	43.65M	45.26M	48.38M	44.71M	44.11M	46.6M	43.4M	40.72M	37.8M	32.75M	30.42M	35.5M	37.88M	37.68M	36.11M	29.4M	24.67M	21.77M	21.45M	22.11M	23.8M	25.45M	26.89M	26.9M	26.64M	24.22M
Income Tax Expense	-2.58M	-2.58M	-3.45M	-5.87M	-2.53M	-2.53M	-2.41M	-870.54K	-763.68K	-762.68K	-760.67K	104.8K	-90	2.36K	1.3K	10.59K	1.64M	1.63M	1.6M	1.6M	-25.79K	-26.74K	1.39K	2.46B	2.46B	2.46B	2.46B	1.97M	1.97M	1.97M
Shares Outstanding (Basic)	2.59M	1.79M	1.79M	1.79M	1.79M	1.78M	1.7M	1.7M	1.3M	1.22M	1.22M	997.87K	486.91K	484.02K	484.02K	302.95K	285.12K	250.88K	250.88K	231.24K	158.15K	101.44K	101.45K	94.11K	89.69K	86.46K	86.46K	77.14K	76.19K	67.39K
Shares Outstanding (Diluted)	2.59M	1.79M	1.79M	1.79M	1.79M	1.78M	1.7M	1.7M	1.3M	1.22M	1.22M	997.87K	486.91K	484.02K	484.02K	302.95K	285.12K	250.88K	250.88K	231.24K	158.15K	101.44K	101.45K	94.11K	89.69K	86.46K	86.46K	77.14K	76.19K	67.39K
EPS (Basic)	-15.67	-18.56	-19.07	-21.42	-23.49	-26.16	-31.59	-32.01	-36.47	-56.26	-65.56	-73.69	-86.39	-87.55	-97.58	-131.66	-159.49	-198.21	-225.91	-234.47	-232.38	-224.56	-231.47	-249.23	-281.81	-314.12	-353.73	-375.41	-401.03	-391.18
EPS (Diluted)	-15.67	-18.56	-19.07	-21.42	-23.49	-26.16	-31.59	-32.01	-36.47	-56.26	-65.56	-73.69	-86.39	-87.55	-97.58	-131.66	-159.49	-198.21	-225.91	-234.47	-232.38	-224.56	-231.47	-249.23	-281.81	-314.12	-353.73	-375.41	-401.03	-391.18
EBITDA	-32.01M	-33.76M	-36.21M	-42.02M	-42.94M	-44.28M	-47.56M	-43.9M	-43.26M	-45.73M	-42.22M	-39.63M	-36.85M	-32.1M	-29.83M	-35.02M	-36.63M	-33.87M	-32.45M	-25.71M	-21.82M	-21.39M	-21.07M	-21.73M	-23.41M	-25.07M	-26.53M	-26.58M	-26.25M	-23.7M
EBIT	-32.67M	-35.74M	-37.49M	-43.49M	-43.35M	-44.15M	-47.56M	-43.2M	-33.76M	-36.69M	-33.23M	-30.9M	-37.78M	-32.69M	-30.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	992.33K	1.29M	1.1M	1.03M	1M	975.66K	1.08M	1.06M	1.1M	1.13M	1.18M	1.08M	943.44K	646.74K	583.58K	478.29K	1.24M	3.81M	3.66M	3.69M	2.85M	381.21K	379.99K	386.24K	393.02K	385.24K	355.58K	316.48K	384.55K	518.37K